123rd SIMI National Congress: Kedrion supports the internist community
The company supports a symposium on Sideropenic Anemia
Guelfo Marcucci awards assigned to two young scientists
The award consists of two scholarships assigned to research projects in the field of non-oncological hematology
Cooperation between Italy and Palestine: Kedrion supports HAEMO-PAL
The company continues its humanitarian commitment to ethical projects in disadvantaged countries
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Announced appointment of Ugo Di Francesco as CEO
PHARMAMARK, the fifth edition of the Pharmaceutical Marketing Master’s Degree has just ended
The aim of the course, which Kedrion has supported from the first edition, is to train future sector managers
Kedrion Biopharma Recognized for innovation in Treating Rare Disease
Prestigious recognition presented for the first ever treatment for Plasminogen Deficiency
SIMTI 2022 Conference: Kedrion alongside the world of blood transfusion
A scientific symposium on Iron deficiency anemia and ferric derisomaltose
Kedrion and IPOPI: the journey continues at the 2022 IPIC
The Primary Immunodeficiencies International Congress took place during World PI Week
World Hemophilia Day: Kedrion’s commitment
Guaranteeing equitable access to treatment is the central theme of the 2022 edition
Kedrion alongside patients with Neuromuscular Disorders
The Company supports the day dedicated to this group of rare diseases for the fifth consecutive year
